Marshall Wace’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-207,873
| Closed | -$5.02M | – | 3044 |
|
|
2025
Q1 | $5.02M | Buy |
207,873
+187,759
| +933% | +$4.53M | 0.01% | 988 |
|
|
2024
Q4 | $809K | Buy |
20,114
+2,256
| +13% | +$90.8K | ﹤0.01% | 1702 |
|
|
2024
Q3 | $1.13M | Sell |
17,858
-55,842
| -76% | -$3.54M | ﹤0.01% | 1480 |
|
|
2024
Q2 | $3.91M | Sell |
73,700
-297,986
| -80% | -$15.8M | 0.01% | 1000 |
|
|
2024
Q1 | $30.5M | Buy |
371,686
+268,831
| +261% | +$22M | 0.05% | 326 |
|
|
2023
Q4 | $1.91M | Buy |
102,855
+50,297
| +96% | +$936K | ﹤0.01% | 1026 |
|
|
2023
Q3 | $582K | Sell |
52,558
-80,632
| -61% | -$893K | ﹤0.01% | 1399 |
|
|
2023
Q2 | $2.16M | Buy |
133,190
+48,467
| +57% | +$786K | ﹤0.01% | 1123 |
|
|
2023
Q1 | $1.41M | Buy |
84,723
+14,388
| +20% | +$240K | ﹤0.01% | 1293 |
|
|
2022
Q4 | $661K | Sell |
70,335
-1,267,045
| -95% | -$11.9M | ﹤0.01% | 1722 |
|
|
2022
Q3 | $3.64M | Buy |
+1,337,380
| New | +$3.64M | 0.01% | 1314 |
|